Psychotherapy Feasibility Pilot of the Carolina Recovery From Depression Protocol
CARED
Psychotherapy Feasibility and Acceptability Pilot of the Carolina Recovery From Depression Protocol (CARED): A Novel Rapid Treatment Paradigm for Depression
1 other identifier
interventional
10
1 country
1
Brief Summary
The goal of this clinical trial is to learn whether an single session intervention can reduce psychological impairment in adult individuals with moderate depression. The main questions it aims to answer are: Is this evidence-based intervention acceptable to study participants? Is this evidence-based intervention feasible to implement in a single session? Is there evidence that the evidence-based intervention reduces psychological impairment in adults with moderate to severe depression? Participants will complete:
- an in-depth diagnostic screening interview prior to enrollment
- a set of mental health questionnaires at baseline and two weeks post-intervention
- a 3-hour, evidence-based, single session psychotherapeutic intervention with a trained clinician
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Start
First participant enrolled
March 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 24, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 24, 2025
CompletedJune 4, 2025
May 1, 2025
2 months
September 5, 2024
June 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
CARED Treatment Experience Survey
A brief survey which probes the qualitative experience of participants during the intervention (i.e., tolerability, their level of engagement, satisfaction with treatment). Participants respond to eight items, rated on a 4-point Likert scale (1 - Not at all to 4 - Completely) to indicate their level of agreement with each item. Higher scores on the measure indicate greater tolerability, satisfaction, and endorsement of treatment. Total possible scores range from 8 to 32.
Immediately post-intervention (same day)
Secondary Outcomes (14)
Change from baseline on Behavioral Activation Scale at two weeks post-intervention
Baseline and Two Weeks post-intervention
Change in baseline Repetitive Thinking Questionnaire - 10 item form to two weeks post-intervention
Baseline and Two weeks post-intervention
Change from baseline on Snaith-Hamilton Pleasure Scale at two weeks post-intervention
Baseline and Two weeks post-intervention
Change from baseline on Behavioral Inhibition and Behavioral Activation Scale - Inhibition Subscale at two weeks post-intervention
Baseline and Two weeks post-intervention
Change from baseline on Behavioral Inhibition and Behavioral Activation Scale - Activation Drive Subscale at two weeks post-intervention
Baseline and Two weeks post-intervention
- +9 more secondary outcomes
Study Arms (1)
Psychotherapy Arm
EXPERIMENTALInterventions
This is a single session intervention which incorporates elements from second- and third wave psychotherapies (Acceptance and Commitment Therapy and Behavioral Activation), as well as basic psychoeducation. Session will take approximately three hours in total, with the option for breaks between blocks of session.
Eligibility Criteria
You may qualify if:
- Age of 18 years or older
- Able to provide informed consent
- Willing to comply with all study procedures and be available for the duration of the study
- Speak and understand English
- Diagnostic and Statistical Manual (DSM)-5 diagnosis of major depressive disorder (MDD) as confirmed by semi-structured clinical assessment
- Meet a cutoff of at least a moderate depression score on the Beck Depression Inventory (BDI-II) (≥ 20)
You may not qualify if:
- Participants must not have current active suicide intent as determined by the Columbia Suicide Severity Rating Scale (C-SSRS)
- Participants must not meet criteria for current severe substance use disorder, anorexia nervosa, or active psychosis as assessed by psychodiagnostic assessment
- Any participants taking psychotropic medication must be on a stable dose for at least 4 weeks with no planned dose changes within the next 4 weeks.
- Participants able to birth must not be pregnant or breastfeeding.
- Participants may not have any medical or neurological illness for which symptom presentation or treatment could interfere with study participation
- Participants may not have undergone prior brain surgery
- Participants may not have any brain devices/implants, including cochlear implants and aneurysm clips
- Participants may not have had brain injury or concussion within the last three months
- Participants may not have a history of brain injury requiring current treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Carolina Center for Neurostimulation
Chapel Hill, North Carolina, 27516, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Flavio Frohlich, Ph.D.
Univeristy of North Carolina Chapel Hill
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 5, 2024
First Posted
September 19, 2024
Study Start
March 3, 2025
Primary Completion
April 24, 2025
Study Completion
April 24, 2025
Last Updated
June 4, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Individual participant data (IPD) and supporting information will be available nine to thirty-six months following publication.
- Access Criteria
- Individual researchers and research groups will be able to request access to deidentified IPD and supporting information with approved IRB, IEC, or REB and an executed Data Use Agreement (DUA) with University of North Carolina (UNC) Chapel Hill.
Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.